drugset / Trial / NCT02535949

Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury

NCT02535949

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the effects of TXA on the immune system, its pharmacokinetics, as well as safety and efficacy in severely injured trauma patients.

Timeline

Start
2016-02
Primary completion
2017-07-04
Completion
2017-07-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 2 g Intravenous
Subject Tranexamic Acid Small molecule 4 g Intravenous

Indications